No connection

Search Results

OSRH vs ZJYL

OSRH
OSR Holdings, Inc.
BEARISH
Price
$0.55
Market Cap
$18.1M
Sector
Healthcare
AI Confidence
95%
ZJYL
Jin Medical International Ltd.
BEARISH
Price
$2.15
Market Cap
$16.9M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
OSRH
--
ZJYL
10.78
Forward P/E
OSRH
--
ZJYL
--
P/B Ratio
OSRH
0.19
ZJYL
0.57
P/S Ratio
OSRH
6.23
ZJYL
0.82
EV/EBITDA
OSRH
-7.78
ZJYL
7.14

Profitability

Gross Margin
OSRH
19.14%
ZJYL
30.18%
Operating Margin
OSRH
-1674.81%
ZJYL
9.83%
Profit Margin
OSRH
0.0%
ZJYL
5.76%
ROE
OSRH
-20.03%
ZJYL
4.75%
ROA
OSRH
-6.62%
ZJYL
0.77%

Growth

Revenue Growth
OSRH
-58.3%
ZJYL
-16.5%
Earnings Growth
OSRH
--
ZJYL
-32.0%

Financial Health

Debt/Equity
OSRH
0.03
ZJYL
0.64
Current Ratio
OSRH
0.16
ZJYL
1.85
Quick Ratio
OSRH
0.12
ZJYL
1.53

Dividends

Dividend Yield
OSRH
--
ZJYL
--
Payout Ratio
OSRH
0.0%
ZJYL
0.0%

AI Verdict

OSRH BEARISH

OSRH exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9 and a catastrophic Current Ratio of 0.16, indicating an inability to meet short-term obligations. The company is experiencing a collapse in top-line growth with revenue declining 58.30% YoY, coupled with an unsustainable operating margin of -1674.81%. While the Price-to-Book ratio of 0.19 suggests deep value, the lack of liquidity and negative earnings trajectory point toward a high risk of insolvency. The single analyst target of $10.00 is completely decoupled from the current fundamental reality.

Strengths
Very low Debt/Equity ratio (0.03)
Trading significantly below book value (P/B 0.19)
Recent short-term price momentum (1-month +21.5%)
Risks
Severe liquidity crisis (Current Ratio 0.16)
Rapidly declining revenue (-58.30% YoY)
Extreme operational inefficiency (Operating Margin -1674.81%)
ZJYL BEARISH

ZJYL presents a classic 'value trap' scenario, characterized by a stable Piotroski F-Score of 6/9 and a price significantly below its Graham Number ($4.13), yet plagued by severe fundamental decay. While the company maintains a healthy balance sheet with a current ratio of 1.85 and low debt/equity (0.64), it is suffering from catastrophic growth contraction, with revenue down 16.5% and earnings down 32% YoY. The massive 87.7% decline in share price over the last year reflects a market that has completely lost confidence in the company's growth trajectory. Despite trading at a deep discount to book value (P/B 0.57), the lack of positive catalysts and bearish technical trend outweigh the valuation appeal.

Strengths
Trading significantly below book value (P/B 0.57)
Stable financial health indicated by Piotroski F-Score of 6/9
Strong liquidity position with a Current Ratio of 1.85
Risks
Severe revenue contraction (-16.5% YoY)
Sharp decline in earnings growth (-32% YoY)
Catastrophic 1-year price performance (-87.7%)

Compare Another Pair

OSRH vs ZJYL: Head-to-Head Comparison

This page compares OSR Holdings, Inc. (OSRH) and Jin Medical International Ltd. (ZJYL) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile